![Opinion on medicine for use outside EU: Mosquirix, RTS,S [Portion of P. falciparum circumsporozoite protein fused with hepatitis B surface antigen (RTS), and combined with hepatitis B surface antigen (S)], Malaria, 23/07/2015 Positive opinion](https://www.ema.europa.eu/sites/default/files/styles/oe_bootstrap_theme_medium_no_crop/public/2024-07/EMA_building_202407_v1-copyright-EMA.png?itok=NBYia_Eu)
From risk to resilience: Energy as a competitive edge
Changes in global energy create risks for businesses, but also a chance to secure a competitive edge
Changes in global energy create risks for businesses, but also a chance to secure a competitive edge
